Genomic assays for lobular breast carcinoma

BACKGROUND: One of the current challenges in breast cancer is the appropriate treatment of invasive lobular breast cancer (ILC) and defining the high-risk group within ILC. The biological character of ILC typically translates to a good prognosis, however, several studies have indicated that the long...

Descripción completa

Detalles Bibliográficos
Autores principales: Göker, Menekse, Denys, Hannelore, van de Vijver, Koen, Braems, Geert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Whioce Publishing Pte. Ltd. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706320/
https://www.ncbi.nlm.nih.gov/pubmed/36451999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706320/
https://www.ncbi.nlm.nih.gov/pubmed/36451999

Ejemplares similares